Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel
John T. Brandt(Eli Lilly (United States)), Sandra Close(Eli Lilly (United States)), Stephen J. Iturria(Eli Lilly (United States)), Christopher D. Payne(Eli Lilly (United Kingdom)), Nazar Farid(Eli Lilly (United States)), C. Steven Ernest(Eli Lilly (United States)), D. Richard Lachno(Eli Lilly (United Kingdom)), Daniel E. Salazar(Daiichi Sankyo (United States)), Kenneth J. Winters(Eli Lilly (United States))
Cited by 729
Abstract
Related Papers
No related papers found
Powered by citation graph analysis